Ad
related to: patented medicine prices canada
Search results
Results from the WOW.Com Content Network
The Patented Medicine Prices Review Board (PMPRB; French: Conseil d'examen du prix des médicaments brevetés) is a federal quasi-judicial regulatory and reporting agency in Canada with a mandate to protect consumers by ensuring that the prices of patented medication charged by manufacturers of patented drugs are not excessive.
The main difference is that patented drug prices in Canada average between 35% and 45% lower than in the United States, though generic prices are higher. [98] The price differential for brand-name drugs between the two countries has led Americans to purchase upward of $1 billion US in drugs per year from Canadian pharmacies. [99]
In Canada, the medication pricing is overseen by the Patented Medicine Prices Review Board (PMPRB), which monitors the prices set for patented drugs. [62] One way the PMPRB evaluates whether drug pricing by patentees is excessive by considering international drug pricing. [63] The PMPRB also compares the price of the drug to a similar market. [64]
In Canada, the Patented Medicine Prices Review Board (PMPRB) determines a maximum price for all drugs. In 1987, Bill C-22 established an extended period of protection for patents prior to licensing, which would allow for generics to enter the market.
Category: Pharmacy organizations in Canada. ... Patented Medicine Prices Review Board This page was last edited on 31 December 2017, at 18:05 (UTC). ...
For premium support please call: 800-290-4726 more ways to reach us
In Canada, the Patented Medicine Prices Review Board examines drug pricing and determines if a price is excessive or not. In these circumstances, drug manufacturers must submit a proposed price to the appropriate regulatory agency.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Ad
related to: patented medicine prices canada